Viventium is dedicated to inventing and developing enabling technology platforms for the cell and gene therapy industry. These platforms will not only provide solutions for the efficient research and development of current therapies but also open the door to the next generation of therapies and cures for unmet medical needs. The platforms can be made available to partners through various structures providing flexibility to licensees with different financial and technical requirements.

Please contact us for questions and available licensing options.